UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 777

Sortiert nach

Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin

PloS one, 2019-02, Vol.14 (2), p.e0211096-e0211096

2019

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics and Dosing Optimization of Imipenem in Children with Hematological Malignancies

Antimicrobial agents and chemotherapy, 2019-06, Vol.63 (6)

2019

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Efficacy of Relebactam (MK-7655) in Combination with Imipenem-Cilastatin in Murine Infection Models

Antimicrobial agents and chemotherapy, 2018-08, Vol.62 (8)

2018

Link zum Volltext

Verfügbarkeit prüfen

Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019

Clinical infectious diseases, 2022-10, Vol.75 (Suppl 3), p.S379-S391

2022

Link zum Volltext

Verfügbarkeit prüfen

Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections

Internal and emergency medicine, 2021-11, Vol.16 (8), p.2231-2241

2021

Link zum Volltext

Verfügbarkeit prüfen

Reversible black tongue: A little known side effect of imipenem/cilastatin and evidence for novel mode of action

Journal of clinical pharmacy and therapeutics, 2020-04, Vol.45 (2), p.370-372

2020

Link zum Volltext

Verfügbarkeit prüfen

Investigating the need for therapeutic drug monitoring of imipenem in critically ill patients: Are we getting it right?

South African medical journal, 2021-09, Vol.111 (9), p.903-909

2021

Link zum Volltext

Verfügbarkeit prüfen

Carbapenems: Past, Present, and Future

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.4943-4960

2011

Link zum Volltext

Verfügbarkeit prüfen

Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial

The Lancet infectious diseases, 2018-12, Vol.18 (12), p.1319-1328

2018

Link zum Volltext

Verfügbarkeit prüfen

Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects

Antimicrobial agents and chemotherapy, 2018-03, Vol.62 (3)

2018

Link zum Volltext

Verfügbarkeit prüfen

Beneficial herb-drug interaction of rhein in Jinhongtang and Imipenem/Cilastatin mediated by organic anion transporters

Journal of ethnopharmacology, 2023-08, Vol.312, p.116449-116449, Article 116449

2023

Link zum Volltext

Verfügbarkeit prüfen

Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model

British journal of pharmacology, 2024-03, Vol.181 (5), p.670-680

2024

Link zum Volltext

Verfügbarkeit prüfen

Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients

Critical care (London, England), 2017-12, Vol.21 (1), p.318-318, Article 318

2017

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of Imipenem/Cilastatin: Considerations for Musculoskeletal Embolotherapy

Journal of vascular and interventional radiology, 2021-07, Vol.32 (7), p.1040-1043.e1

2021

Link zum Volltext

Verfügbarkeit prüfen

Two-year outcomes comparing Embosphere® microspheres versus Imipenem Cilastatin for genicular artery embolization in patients with moderate to severe knee osteoarthritis

The knee, 2023-03, Vol.41, p.38-47

2023

Link zum Volltext

Verfügbarkeit prüfen

Imipenem/relebactam pharmacokinetics in critically ill patients supported on extracorporeal membrane oxygenation

Journal of antimicrobial chemotherapy, 2024-05, Vol.79 (5), p.1118-1125

2024

Link zum Volltext

Verfügbarkeit prüfen

Early outcomes of transcatheter arterial embolization using imipenem/cilastatin for plantar fasciitis refractory to conservative therapy

British journal of radiology, 2024-02, Vol.97 (1155), p.544-548

2024

Link zum Volltext

Verfügbarkeit prüfen

Safety, Pharmacokinetics, and Drug-Drug Interaction Potential of Intravenous Durlobactam, a β-Lactamase Inhibitor, in Healthy Subjects

Antimicrobial agents and chemotherapy, 2020-06, Vol.64 (7)

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections

Antimicrobial agents and chemotherapy, 2020-04, Vol.64 (5)

2020

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK)

Antimicrobial agents and chemotherapy, 2024-05, Vol.68 (5), p.e0169823

2024

Link zum Volltext

Verfügbarkeit prüfen

Adverse Events Associated With Meropenem Versus Imipenem/Cilastatin Therapy in a Large Retrospective Cohort of Hospitalized Infants

The Pediatric infectious disease journal, 2013-07, Vol.32 (7), p.748-753

2013

Link zum Volltext

Verfügbarkeit prüfen

A novel analytical method to assess the effect of imipenem/cilastatin on liver function laboratory indexes in Chinese underage inpatients: Probability distribution curve

PloS one, 2019-10, Vol.14 (10), p.e0224352-e0224352

2019

Link zum Volltext

Verfügbarkeit prüfen

Human anaplasmosis and Anaplasma ovis variant

Emerging infectious diseases, 2010-06, Vol.16 (6), p.1031-1032

2010

Link zum Volltext

Verfügbarkeit prüfen

Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms

Journal of the Pediatric Infectious Diseases Society, 2019-07, Vol.8 (3), p.251-260

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 777

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(649)
Mit Volltextzugriff
(543)

Publikationsform

Artikel
(774)
magazinearticle
(3)

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(707)
Female
(457)
Drug Combinations
(449)
Male
(449)
Science & Technology
(430)
Life Sciences & Biomedicine
(428)
Adult
(371)
Imipenem - Therapeutic Use
(363)
Cilastatin - Therapeutic Use
(362)
Middle Aged
(341)
Aged
(295)
Bacterial Infections - Drug Therapy
(261)
Imipenem
(250)
Cilastatin
(214)
Anti-Bacterial Agents - Therapeutic Use
(203)
Biological And Medical Sciences
(202)
Medical Sciences
(201)
Imipenem - Administration & Dosage
(199)
Cilastatin - Administration & Dosage
(195)
Pharmacology. Drug Treatments
(170)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin

Population Pharmacokinetics and Dosing Optimization of Imipenem in Children with Hematological Malignancies

In Vivo Efficacy of Relebactam (MK-7655) in Combination with Imipenem-Cilastatin in Murine Infection Models

Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019

Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections

Reversible black tongue: A little known side effect of imipenem/cilastatin and evidence for novel mode of action

Investigating the need for therapeutic drug monitoring of imipenem in critically ill patients: Are we getting it right?

Carbapenems: Past, Present, and Future

Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice

Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial

Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects

Beneficial herb-drug interaction of rhein in Jinhongtang and Imipenem/Cilastatin mediated by organic anion transporters

Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model

Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients

Characteristics of Imipenem/Cilastatin: Considerations for Musculoskeletal Embolotherapy

Two-year outcomes comparing Embosphere® microspheres versus Imipenem Cilastatin for genicular artery embolization in patients with moderate to severe knee osteoarthritis

Imipenem/relebactam pharmacokinetics in critically ill patients supported on extracorporeal membrane oxygenation

Early outcomes of transcatheter arterial embolization using imipenem/cilastatin for plantar fasciitis refractory to conservative therapy

Safety, Pharmacokinetics, and Drug-Drug Interaction Potential of Intravenous Durlobactam, a β-Lactamase Inhibitor, in Healthy Subjects

Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections

Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK)

Adverse Events Associated With Meropenem Versus Imipenem/Cilastatin Therapy in a Large Retrospective Cohort of Hospitalized Infants

A novel analytical method to assess the effect of imipenem/cilastatin on liver function laboratory indexes in Chinese underage inpatients: Probability distribution curve

Human anaplasmosis and Anaplasma ovis variant

Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms

Suchergebnisse filtern